Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals

Journal of General Internal Medicine

Volumn 21, Issue 12, 2006, Pages 1248-1252

  Cooper, Richelle J ^a   Gupta, Malkeet ^a   Wilkes, Michael S ^b   Hoffman, Jerome R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Conflict of interest; Disclosure; Editorial policy; Peer review

Indexed keywords

ARTICLE; AUTHOR; CONFLICT OF INTEREST; EDITOR; HEALTH SURVEY; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; MEDICAL EXPERT; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL RESEARCH; PEER REVIEW; PREVALENCE; PUBLICATION; PUBLISHING; QUESTIONNAIRE;

EID: 33750505437     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2006.00598.x     Document Type: Article

References (17)

1. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA. 2005;294:110-1.
2. Davidoff F, DeAngelis CD, Drazen JM, et al. Sponsorship, authorship, and accountability. N Engl J Med. 2001;345:825-6; discussion 826-7.
3. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998;338:101-6.
4. Krimsky S, Rothenberg LS, Stott P, Kyle G. Financial interests of authors in scientific journals: a pilot study of 14 publications. Sci Eng Ethics. 1996;2:395-410.
5. Friedman LS, Richter ED. Relationship between conflicts of interest and research results. J Gen Intern Med. 2004;19:51-6.
6. Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Can Med Assoc J. 2004;170:477-80.
7. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326:1167-70.
8. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials. A reflection of treatment effect or adverse events? JAMA. 2003;290:921-8.
9. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002;287:612-7.
10. Kjaergard LL, Als-Nielsen B. Association between competing interests and author's conclusions: epidemiological study of randomized clinical trials published in the BMJ. BMJ. 2002;325:249-52.
11. Yaphe J, Edman R, Knishkowy B, Herman J. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract. 2001;18:565-8.
12. World Association of Medical Editors (WAME).WAME recommendations on publication ethics policies for medical journals. Available at http://wame.org/pubethicrecom.htm#conflicts. Accessed August 22, 2005.
13. International Council of Medical Journal Editors (ICMJE). Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. Available at http://www.icmje.org/ #conflicts. Accessed August 22, 2005.
14. Committee on Publication Ethics (COPE). A code of conduct for editors of biomedical journals. Available at http://www.bmjpg.com/cope/guidelines/. Accessed August 22, 2005.
15. Haivas I, Schroter S, Waechter F, Smith R. Editors declaration of their own conflicts of interest. Can Med Assoc J. 2004;171:475-6.
16. ISI Web of Knowledge Journal Database Version 2005. Available at http://www.thomsonisi.com/. Accessed January 27, 2005.
17. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. [PLoS Med 2005 May 2:e138, DOI: 10.1371/journal.pmed. 0020138].